Effects of the Mitochondria-Targeted Drug Elamipretide on Leakage-Independent Vision Loss in Fellow Eyes with Neovascular AMD in the ReCLAIM Study
Publication
, Conference
Mettu, PS; Allingham, MJ; Cousins, SW
Published in: INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
July 1, 2019
Duke Scholars
Published In
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
EISSN
1552-5783
ISSN
0146-0404
Publication Date
July 1, 2019
Volume
60
Issue
9
Location
Vancouver, CANADA
Publisher
ASSOC RESEARCH VISION OPHTHALMOLOGY INC
Conference Name
Annual Meeting of the Association-for-Research-in-Vision-and-Ophthalmology (ARVO)
Related Subject Headings
- Ophthalmology & Optometry
- 3212 Ophthalmology and optometry
- 11 Medical and Health Sciences
- 06 Biological Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Mettu, P. S., Allingham, M. J., & Cousins, S. W. (2019). Effects of the Mitochondria-Targeted Drug Elamipretide on Leakage-Independent Vision Loss in Fellow Eyes with Neovascular AMD in the ReCLAIM Study. In INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (Vol. 60). Vancouver, CANADA: ASSOC RESEARCH VISION OPHTHALMOLOGY INC.
Mettu, Priyatham S., Michael John Allingham, and Scott W. Cousins. “Effects of the Mitochondria-Targeted Drug Elamipretide on Leakage-Independent Vision Loss in Fellow Eyes with Neovascular AMD in the ReCLAIM Study.” In INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, Vol. 60. ASSOC RESEARCH VISION OPHTHALMOLOGY INC, 2019.
Mettu PS, Allingham MJ, Cousins SW. Effects of the Mitochondria-Targeted Drug Elamipretide on Leakage-Independent Vision Loss in Fellow Eyes with Neovascular AMD in the ReCLAIM Study. In: INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE. ASSOC RESEARCH VISION OPHTHALMOLOGY INC; 2019.
Mettu, Priyatham S., et al. “Effects of the Mitochondria-Targeted Drug Elamipretide on Leakage-Independent Vision Loss in Fellow Eyes with Neovascular AMD in the ReCLAIM Study.” INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, vol. 60, no. 9, ASSOC RESEARCH VISION OPHTHALMOLOGY INC, 2019.
Mettu PS, Allingham MJ, Cousins SW. Effects of the Mitochondria-Targeted Drug Elamipretide on Leakage-Independent Vision Loss in Fellow Eyes with Neovascular AMD in the ReCLAIM Study. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE. ASSOC RESEARCH VISION OPHTHALMOLOGY INC; 2019.
Published In
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
EISSN
1552-5783
ISSN
0146-0404
Publication Date
July 1, 2019
Volume
60
Issue
9
Location
Vancouver, CANADA
Publisher
ASSOC RESEARCH VISION OPHTHALMOLOGY INC
Conference Name
Annual Meeting of the Association-for-Research-in-Vision-and-Ophthalmology (ARVO)
Related Subject Headings
- Ophthalmology & Optometry
- 3212 Ophthalmology and optometry
- 11 Medical and Health Sciences
- 06 Biological Sciences